Company: VRCA
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0001193125-25-079118
Chunk: 26

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 26
---
 its independent registered public accounting firm for ratification by the stockholders at the annual meeting. KPMG LLP has audited the Company’s financial statements since 2017. Representatives of KPMG LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions. Neither the Company’s Bylaws nor other governing documents or law require stockholder ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm. However, the Audit Committee of the Board is submitting the selection of KPMG LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of the Company and its stockholders. The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the matter at the annual meeting will be required to ratify the selection of KPMG LLP. Fees for Services Provided by the Independent Registered Public Accounting Firm The following table represents aggregate fees for professional services rendered to the Company for the years ended December 31, 2024 and 2023 by KPMG LLP, the Company’s independent registered public accounting firm.

|               |     | Years Ended December 31, |    2024 |     |   |    2023 |
|:--------------|:----|:-------------------------|--------:|:----|:--|--------:|
| Audit Fees(1) |     | $                        | 684,000 |     | $ | 475,019 |
| Tax Fees(2)   |     |                          |  89,861 |     |   | 126,151 |
| Total Fees    |     | $                        | 773,861 |     | $ | 601,170 |

| (1) | Audit fees for the fiscal years ended December 31, 2024 and 2023 include fees in connection with services rendered for the audit and quarterly review of our financial statements filed with the SEC on Form 10-K and 10-Q in addition to professional services related to financial procedures performed in connection with securities offerings